chr1-6628680-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The ENST00000054650.9(THAP3):c.256G>A(p.Asp86Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000345 in 1,612,890 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
ENST00000054650.9 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
THAP3 | NM_001195753.2 | c.256G>A | p.Asp86Asn | missense_variant | 3/6 | ENST00000054650.9 | NP_001182682.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
THAP3 | ENST00000054650.9 | c.256G>A | p.Asp86Asn | missense_variant | 3/6 | 1 | NM_001195753.2 | ENSP00000054650.4 |
Frequencies
GnomAD3 genomes AF: 0.000348 AC: 53AN: 152200Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000387 AC: 96AN: 248106Hom.: 0 AF XY: 0.000431 AC XY: 58AN XY: 134500
GnomAD4 exome AF: 0.000345 AC: 504AN: 1460572Hom.: 0 Cov.: 31 AF XY: 0.000334 AC XY: 243AN XY: 726500
GnomAD4 genome AF: 0.000348 AC: 53AN: 152318Hom.: 0 Cov.: 33 AF XY: 0.000430 AC XY: 32AN XY: 74484
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 27, 2021 | The c.256G>A (p.D86N) alteration is located in exon 3 (coding exon 2) of the THAP3 gene. This alteration results from a G to A substitution at nucleotide position 256, causing the aspartic acid (D) at amino acid position 86 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at